News and Press Releases
Awen Oncology secures significant new funds to advance pioneering cancer therapeutics
23 April 2026 -- Anglesey, UK -- Awen Oncology, a pioneering Wales-based therapeutics company developing next-generation cancer treatments, has secured funds from a number of sources, worth seven figures, which...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 23, 2026
SeaBeLife secures €2 million
This funding will help fast-track the launch of clinical trials in dry AMD and severe acute hepatitis programs 1 October 2025 -- Roscoff, France -- SeaBeLife, a biotechnology company developing...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 1, 2025
PACE launches its third funding round today, supporting innovative projects that tackle resistant bacterial infections posing the greatest threat to global health
1 October 2025 -- Alderley Park, UK -- To stay ahead of the escalating antibiotic resistance crisis, we need bold thinking and transformative innovation. According to the World Health Organization...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 1, 2025
Shift Bioscience establishes North American facilities to expand capabilities of AI-powered virtual cell technology
Head of Machine Learning, Lucas Camillo, to lead team with Professor Bo Wang, University of Toronto, appointed as Senior Advisor Expansion into global AI hub to accelerate growth of IP...
Category: Biotechnology, Drug Discovery
Posted: February 18, 2025
Shift Bioscience Ltd The Gurdon Institute Tennis Court Road Cambridge CB2 1QN United Kingdom
Bioxodes secures new funds to reach early 2025 milestones and pursue Series B financing
Bioxodes raises €2.7 million from existing investors in Series A extension Interim data from BIRCH intracerebral hemorrhage (ICH) Phase 2a trial in Q1 2025 Recruitment of up to 16 additional...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 12, 2025
ENEA-Tech Biomedical Foundation Invests €6m in BetaGlue® Therapeutics
Brings 2024 Funding Round Total to €24m 16 December 2024 -- Milan, Italy -- BetaGlue Therapeutics S.p.A, an Italian clinical-stage oncology company developing an innovative radiotherapy platform for the targeted...
Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: December 16, 2024
BetaGlue Therapeutics SpA. Piazzetta Umberto Giordano 4, 20122 Milan, Italy
Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company
12 December 2024 – London, UK, and Palo Alto, CA, US – Deep Science Ventures, a UK-based venture studio, and General Inception, a US-based venture studio, today announced a collaboration...
Category: Drug Discovery, Other
Posted: December 12, 2024
Accelerating Innovation in Research and Diagnostics with Science-Aware AI
10 December 2024 –Baltimore, MD, US – Sapio Sciences, the science-aware™ lab informatics platform, today announced the highly anticipated speaker lineup and agenda for SapioCon 2025. Taking place from February...
Category: BioManufacturing, Biotechnology, Drug Discovery
Posted: December 10, 2024
Slow uptake of centralised data processes is preventing analytic maturity in manufacturing and supply chain firms, research reveals
Research from Alteryx finds that significant portions of the sector are missing out on more streamlined data analytics functions 5 November 2024 – London, UK – Decentralised data and processes...
Category: Logistics, Manufacturing and Packing
Posted: November 7, 2024
Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI
5 November 2024 –Tokyo, Japan and London and Cardiff, UK – Nxera Pharma (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio...
Category: BioManufacturing
Posted: November 6, 2024
Discover the Power of AI in Biopharma: TVM to host thought-provoking sessions at BIO-Europe 2024
30 October 2024 – Munich, Germany and Montreal, Quebec, Canada – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today...
Category:
Posted: October 31, 2024
TVM Capital GmbH, TVM Life Science Management GmbH, Ottostraße 4, 80333 Munich, Germany
Antiverse raises £3.5M ($4.6M) to advance generative AI antibody design platform
Increases total equity financing raised to £7.2M ($10.1M) New facilities in Boston and Prague will provide increased capacity to deliver pipeline of pharma and biotech projects Funding to progress internal...
Category: Biotechnology, Drug Discovery
Posted: October 17, 2024
RHYTHM AI announces FDA clearance of the commercial release version of STAR Apollo Mapping System
First-in-human cases successfully completed using this new system at Baptist Health, Jacksonville, Florida 23 September 2024, – London, UK – RHYTHM AI Ltd (“RHYTHM AI” or “the Company”), a UK...
Category: Biotechnology, Clinical Trials
Posted: September 23, 2024
Basecamp Research and Cameroon announce pioneering access and benefit-sharing partnership, spotlighting new economic model before COP 16
Access and benefit-sharing agreement showcases Basecamp Research’s unique economic model: Training, data-sharing, molecular lab and in-country research funding for Cameroon scientists Royalties for when digital sequence information collected is used...
Category: Biotechnology
Posted: August 14, 2024
SSI Strategy and Metalmind Partner for Enterprise AI Solutions
23 July 2024 , New Jersey US, Kista, Sweden, – SSI Strategy LLC, a global leader in strategic consulting for life sciences, is pleased to announce a partnership with MPS...
Category: Biotechnology
Posted: July 30, 2024
